This PR sums up

New Post Public Reply Private Reply Replies (0) Message Board
joey68
734
This PR sums up DCTH:

http://delcath.com/reuters-news/?id=2262473

1. DCTH's product has been in use for years in Europe and is doing well:

The product is commercially available in Europe under the trade name CHEMOSAT, and is being evaluated as an investigational therapy in the U.S. Delcath is currently enrolling patients in the FOCUS trial, a global Phase 3 clinical trial that is investigating PHP with Melphalan/HDS as a treatment for patients with ocular melanoma that has metastasized to the liver.

2. This is what it does:

PHP is a minimally invasive procedure that isolates the liver from the body’s circulatory system, so that a high dose of chemotherapy (melphalan hydrochloride) may be infused directly into the liver with the potential to treat both visualized and non-visualized metastases. Blood from the liver is then filtered to remove the chemotherapeutic agent thereby minimizing systemic exposure and potentially the associated side effects.

3. It works:

In the case of Mr. Carney, he was referred to Spire Southampton, and received his first PHP treatment in December 2013. In the intervening period, he has also undergone liver resections and immunotherapy treatments. He recently became the first patient in the world to receive eight PHP treatments, which controlled the tumor and allowed him to conduct normal daily activities at his home.

4. Phase 3 trial in effect for USA:

We have commenced a global Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) and plan to initiate a Registration trial for intrahepatic cholangiocarcinoma (ICC) in the Fall of 2017. Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, our system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver.

Delcath Systems Inc. (DCTH) Stock Research Links

DCTH Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Managed Connectivity: Key to Modern Multifamily Living

Updated Category News Views 2

Connectivity Runs the Modern Show Imagine moving into a shiny new apartment, where the biggest hassle isn't unpacking boxes but ensuring your gadgets get online smoothly. That's the reality of today's multifamily living, where the internet is more than a utility—it's the backbone of modern life. And if you think it's just about offering internet access, you're missing...

Continue Reading
EPR Fireworks, Schedule2.IT Enhance EMS Integration

Updated Category News Views 6

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Continue Reading
MiniCo's New Desk: A Game Changer for E&S Market

Updated Category News Views 2

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Continue Reading
Roof Replacement Timelines: Key Insights for PA Homeowners

Updated Category News Views 6

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost

Updated Category News Views 5

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Continue Reading
Comparent Unveils Key Insights with Top 100 List

Updated Category News Views 3

The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...

Continue Reading
Li-Fire Expands Fire Safety Amid Rising Battery Risks

Updated Category News Views 4

A Crunchy Look at New Fire Safety Moves Well, folks, here's a twist we didn't see coming but sure makes sense in today's electrifying business landscape. Li-Fire, the big brains behind lithium battery fire suppression, is spreading its wings nationwide, or at least its wholesale and distribution programs are. And right ahead of National Fire Safety Week no less—talk...

Continue Reading
Crucial Insights for South GA Home Insurance Choices

Updated Category News Views 5

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

Continue Reading
Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Updated Category News Views 10

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

Continue Reading
Haystack MRD Shines in Colorectal Cancer Trials

Updated Category News Views 1

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Vantage Launches 24/7 Gold CFD Trading Tool

Updated Category News Views 23

Vantage Expands Gold Trading Horizons with XAUUSD247 Alright, folks, in today's trading landscape, the name of the game is flexibility. Vantage, the multi-asset CFD broker, just dropped a veritable bombshell for gold traders with the launch of XAUUSD247. This ain't your granddad's trading setup; we're talking about 24/7 access, right through weekends, offering a sharp...

Continue Reading
Matinas BioPharma Addresses NYSE Listing Compliance Concerns

Updated Category News Views 215

Matinas BioPharma Addresses NYSE Listing Compliance Concerns Matinas BioPharma Holdings, Inc. is making headlines as it navigates the requirements set forth by the NYSE American. Recently, the company received a notification regarding its compliance status, highlighting the importance of adhering to regulatory standards in the competitive biopharmaceutical sector....

Continue Reading
Germany's Economic Struggles: What it Means for Europe in 2024

Updated Category News Views 612

Germany's Economy Faces Continued Challenges in 2024 Germany is navigating turbulent waters as its economy contracts for the second consecutive year, marking a concerning period for Europe’s largest economy. In 2024, the Federal Statistics Office revealed a contraction of 0.1% in the final quarter, leading to an overall decline of 0.2% for the year. This situation...

Continue Reading
Joshua M. Moss Takes on New Role with SenesTech Board

Updated Category News Views 364

Joshua M. Moss Joins the SenesTech Board of Directors SenesTech, Inc. (NASDAQ: SNES), a leader in humane pest control solutions, is thrilled to announce the appointment of Joshua M. Moss to its Board of Directors. His extensive background in investment management and strategic growth is expected to bring valuable insights into the company's future endeavors. Professional...

Continue Reading
Progyny Faces Major Setback After Client Contract Termination

Updated Category News Views 137

Progyny Faces Client Departure Progyny, Inc. (NASDAQ: PGNY), a prominent provider of fertility and family-building benefits, is currently navigating a significant challenge due to the recent announcement of a substantial client terminating its services agreement. This news has created a ripple effect in the investment community as the company assesses the consequences of...

Continue Reading